Hassan Mahmudul
VC Investor @ Future Planet Capital
London, United Kingdom
Hassan Mahmudul is a venture capital investor at Future Planet Capital, he is also a graduate of the Durham University.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Hassan Mahmudul invests in
Stages Hassan Mahmudul invests in
Countries Hassan Mahmudul invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Medical 1 (17%)
- Life Science 1 (17%)
- Test and Measurement 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cytotrait focuses on the development of novel traits for food and agriculture. | $4M / Seed / Mar 09, 2026 | ||
| iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance. | $6.5M / Seed / Nov 04, 2024 | ||
| Adamo Food is a UK-based food tech company developing plant-based whole-cut meats using proprietary fermentation technology combined with mycelium. | $2.5M / Seed / Aug 12, 2024 | ||
| Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom. | $1.6M / Seed / Apr 06, 2023 | ||
| iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance. | $2.4M / Seed / Feb 16, 2023 | ||
| Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existingbio-design limits imposed by conventional peptide synthesis, with one universal process. | Seed / May 27, 2022 |
Co-Investors
About Future Planet Capital
Future Planet is an impact-led venture capital firm that invests in technology and life science companies from leading research centres
Future Planet Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Guy Pengelley
Investment Director
|
|||
Douglas Hansen-Luke
founder
|
|||
|
Hassan Mahmudul
VC Investor
|
|||
Lyle Pentith
Portfolio Manager
|
|||
Oliver Sexton
Head of Life Science
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Hassan Mahmudul invest in?
Hassan Mahmudul invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hassan Mahmudul?
Public channels for Hassan Mahmudul include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Hassan Mahmudul last invest?
The most recent investment recorded for Hassan Mahmudul closed in Mar 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
